Effects of Mefloquine Use on Plasmodium vivax Multidrug Resistance

Use of mefloquine against P. falciparum jeopardizes its future use against P. vivax.

• Publication year

  2014

• Venue

  Emerging Infectious Diseases

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3201/eid2010.140411PMID 25272023PMCID 4193276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

  2013cited by this paper
• Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.

  2013cited by this paper
• Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns.

  2012cited by this paper
• Discordant Temporal Evolution of Pfcrt and Pfmdr1 Genotypes and Plasmodium falciparum In Vitro Drug Susceptibility to 4-Aminoquinolines after Drug Policy Change in French Guiana

  2012cited by this paper
• Performance of “VIKIA Malaria Ag Pf/Pan” (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections

  2012cited by this paper
• Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.

  2012cited by this paper
• Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects

  2011cited by this paper
• Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America

  2011influential reference
• Genetic analysis of a hantavirus strain carried by Niviventer confucianus in Yunnan province, China.

  2010cited by this paper
• Spread and evolution of Plasmodium falciparum drug resistance.

  2009cited by this paper
• Sensitivity of Andes Hantavirus to Antiviral Effect of Human Saliva

  2009cited by this paper
• Ecology, Genetic Diversity, and Phylogeographic Structure of Andes Virus in Humans and Rodents in Chile

  2008cited by this paper
• Gene Amplification of the Multidrug Resistance 1 Gene of Plasmodium vivax Isolates from Thailand, Laos, and Myanmar

  2008cited by this paper
• Hantavirus RNA in Saliva from Patients with Hemorrhagic Fever with Renal Syndrome

  2008cited by this paper
• Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries.

  2008cited by this paper
• Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.

  2008cited by this paper
• Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border

  2008cited by this paper
• Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing.

  2007cited by this paper
• Antifolates can have a role in the treatment of Plasmodium vivax.

  2007cited by this paper
• Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile.

  2007cited by this paper
• Incubation Period of Hantavirus Cardiopulmonary Syndrome

  2006cited by this paper
• Large Punctuational Contribution of Speciation to Evolutionary Divergence at the Molecular Level

  2006cited by this paper
• Person-to-Person Transmission of Andes Virus

  2005cited by this paper
• The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.

  2004cited by this paper
• Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.

  2004cited by this paper
• Prevalence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile.

  2004cited by this paper
• A phylogenetic mixture model for detecting pattern-heterogeneity in gene sequence or character-state data.

  2004cited by this paper
• Hantavirus pulmonary syndrome in Latin America

  2004cited by this paper
• Mixed-species malaria infections in humans.

  2004cited by this paper
• Transmission Study of Andes Hantavirus Infection in Wild Sigmodontine Rodents

  2004cited by this paper
• [Hantavirus pulmonary syndrome: current situation among rodent reservoirs and human population in the 10th region, Chile].

  2003cited by this paper
• Epidemiology of drug-resistant malaria.

  2002cited by this paper
• First Human Isolate of Hantavirus (Andes virus) in the Americas

  2002cited by this paper
• The History of Antimalarial Drugs

  2001influential reference
• Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria.

  2001cited by this paper
• The public health impact of chloroquine resistance in Africa.

  2001cited by this paper
• Bias in phylogenetic estimation and its relevance to the choice between parsimony and likelihood methods.

  2001cited by this paper
• Performance of A 3 MCNP™ for Calculation of 3-D Neutron Flux Distribution in a BWR Core Shroud

  2001cited by this paper
• Efficiencies of fast algorithms of phylogenetic inference under the criteria of maximum parsimony, minimum evolution, and maximum likelihood when a large number of sequences are used.

  2000cited by this paper
• Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein.

  2000cited by this paper
• Genetic Diversity, Distribution, and Serological Features of Hantavirus Infection in Five Countries in South America

  2000cited by this paper
• The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparumfrom the Western Border of Thailand

  1999cited by this paper
• An outbreak of hantavirus pulmonary syndrome, Chile, 1997.

  1998cited by this paper
• Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting.

  1998cited by this paper
• MODELTEST: testing the model of DNA substitution

  1998cited by this paper
• Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus.

  1998cited by this paper
• Hantaviruses: a global disease problem.

  1997cited by this paper
• Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis

  1997cited by this paper
• International Travel and Health

  1997cited by this paper
• An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia.

  1997cited by this paper
• Evidence against person-to-person transmission of hantavirus to health care workers.

  1996cited by this paper
• A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro.

  1994cited by this paper
• Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine.

  1994cited by this paper
• Antimalarial drug resistance: the pace quickens.

  1992cited by this paper
• International Travel and Health: Vaccination Requirements and Health Advice

  1992cited by this paper
• The dynamics of drug resistance in Plasmodium falciparum.

  1991cited by this paper
• The epidemiology of drug-resistant malaria.

  1990influential reference
• [Practical experience with mefloquine as an antimalarial].

  1986cited by this paper
• Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.

  1981cited by this paper
• Pyrimethamine resistance in Plasmodium vivax malaria.

  1959cited by this paper

• A common DNA deletion altering the 3’UTR of mdr1 is associated with reduced mefloquine susceptibility in P. vivax parasites from Cambodian patients

  2026cites this paper
• A common DNA deletion altering the 3’UTR of mdr1 is associated with reduced mefloquine susceptibility in P. vivax parasites from Cambodian patients

  2025cites this paper
• High-resolution in situ structures of hantavirus glycoprotein tetramers

  2025cites this paper
• High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes

  2024cites this paper
• High-Throughput Genotyping of Plasmodium vivax in the Peruvian Amazon via Molecular Inversion Probes

  2024cites this paper
• Global scenario of Plasmodium vivax occurrence and resistance pattern

  2022influential citation
• The molecular basis of antimalarial drug resistance in Plasmodium vivax

  2021cites this paper
• Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes

  2020cites this paper
• Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions

  2020cites this paper
• Molecular surveillance of the Plasmodium vivax multidrug resistance 1 gene in Peru between 2006 and 2015

  2020cites this paper
• New directions in antimalarial target validation

  2020cites this paper
• Dendritic Cells (DCs) as “Fire Accelerants” of Hantaviral Pathogenesis

  2019cites this paper
• A Single-Nucleotide Polymorphism of αVβ3 Integrin Is Associated with the Andes Virus Infection Susceptibility

  2019cites this paper
• The genomic architecture of antimalarial drug resistance

  2019cites this paper
• Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes

  2019cites this paper
• Tula orthohantavirus nucleocapsid protein is cleaved in infected cells and may sequester activated caspase-3 during persistent infection to suppress apoptosis.

  2019cites this paper
• Progress on the Prevention and Treatment of Hantavirus Disease

  2019cites this paper
• Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection

  2019cites this paper
• Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome

  2019cites this paper
• A 19 Year Analysis of Small Mammals Associated with Human Hantavirus Cases in Chile

  2019cites this paper
• Possibility of nosocomial person-to-person transmission of hemorrhagic fever with renal syndrome

  2019cites this paper
• Hemodynamic and Pulmonary Permeability Characterization of Hantavirus Cardiopulmonary Syndrome by Transpulmonary Thermodilution

  2019cites this paper
• Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses

  2019cites this paper
• Early transmission of sensitive strain slows down emergence of drug resistance in Plasmodium vivax

  2019cites this paper
• Commentary: Malaria elimination in India and regional implications

  2018cites this paper
• Hantavirus maintenance and transmission in reservoir host populations.

  2018cites this paper
• The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014

  2018cites this paper
• Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.

  2018cites this paper
• Characterization of clinical features and outcome for human-to-human transmitted severe fever with thrombocytopenia syndrome

  2018cites this paper
• Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA, 2016

  2017cites this paper
• Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope

  2017cites this paper
• Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia

  2017cites this paper
• Knowledge, attitudes, and practices regarding hantavirus disease and acceptance of a vaccine trial in rural communities of southern Chile

  2017cites this paper
• What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?

  2017cites this paper
• Malaria Epidemiology at the Clone Level.

  2017cites this paper
• Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature

  2017cites this paper
• Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana

  2016influential citation
• Extracorporeal membrane oxygenation for the treatment of severe refractory hantavirus cardiopulmonary syndrome

  2016cites this paper
• Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A

  2016cites this paper
• Genetic diversity of the Pvk12 gene in Plasmodium vivax from the China-Myanmar border area

  2016cites this paper
• Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivax

  2015cites this paper
• Serological Evidence of Hantavirus Infection in Apparently Healthy People from Rural and Slum Communities in Southern Chile

  2015cites this paper
• Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses

  2015cites this paper
• Reduced Polymorphism in the Kelch Propeller Domain in Plasmodium vivax Isolates from Cambodia

  2014cites this paper